Furosemide Stress Test Predicting Early Graft Function in Kidney Transplantation
Furosemide Stress Test as a Marker of Postoperative Kidney Allograft Function
King Chulalongkorn Memorial Hospital
180 participants
Nov 25, 2016
INTERVENTIONAL
Summary
Furosemide is an old drug that has been used frequently in the postoperative period of kidney transplantation, aiming to achieve adequate urine output. There is no previous study that directly evaluate the urine response to standardized dose of furosemide in the postoperative period. The objective is to measure the urine output after standardized dose of furosemide is delivered, as a biomarker to predict the graft function in perioperative period.
Eligibility
Inclusion Criteria2
- Deceased donor kidney transplantation at KCMH
- informed consent is accepted
Exclusion Criteria3
- Known allergy to furosemide
- Surgical complication of allograft
- Urgently needed for dialysis (refractory hypervolemia, uremic symptoms, and hyperkalemia)
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Furosemide 1.5 mg/kg intravenously at 3 hours post-reperfusion of kidney allograft
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03071536